GURU.Markets stock price, segment price, and overall market index valuation
The company's share price DXR
Daxor produces a blood volume measuring device that could help treat heart failure. Its stock price is the story of the battle to commercialize this niche but potentially important diagnostic technology.
Share prices of companies in the market segment - Diagnostic medical equipment
Daxor Corporation is a medical device company that developed the BVA-100 system for accurately measuring blood and red blood cell volume in critically ill patients. We classified it in the "Diagnostic Medical Equipment" segment. The graph below shows the overall dynamics in the diagnostic equipment sector, where measurement accuracy saves lives.
Broad Market Index - GURU.Markets
Daxor Corporation is a medical device company that has developed a system for accurately measuring blood volume in patients, which aids in the diagnosis and treatment of heart failure. It is a component of the GURU.Markets index. The chart below represents the market. See how this company's stock compares to the medical device sector.
Change in the price of a company, segment, and market as a whole per day
DXR - Daily change in the company's share price DXR
The daily price change of Daxor Corporation, a manufacturer of blood volume analysis equipment, reflects volatility in the medical device sector. The indicator demonstrates sensitivity to the adoption of its technology in hospitals and clinical data.
Daily change in the price of a set of shares in a market segment - Diagnostic medical equipment
Daxor Corporation is a manufacturer of blood volume analysis equipment. This chart shows the average daily volatility of the MedTech sector. Comparing it to DXR's performance, with its unique niche, helps assess its stability compared to major manufacturers.
Daily change in the price of a broad market stock, index - GURU.Markets
Daxor Corporation produces a diagnostic system for measuring blood volume, which is critical in treating heart failure. The medtech company's stock price is dependent on the implementation of its technology in hospitals, adding to the overall picture of market volatility.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization DXR
Daxor Corporation's year-over-year performance tells the story of its unique diagnostic tool. Its market capitalization growth over the past 12 months reflects the growing number of hospitals using its BVA-100 system to accurately measure blood volume in critically ill patients, helping optimize treatment and improve outcomes.
Annual dynamics of market capitalization of the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of a unique diagnostic system for measuring blood volume. This chart shows how its niche technology, market expansion efforts, and dependence on physician acceptance of its method influence its performance in the medical device sector.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Daxor, with its diagnostic system, is a niche medical company. Its stock price is determined not by the economy, but by the speed of hospital adoption of its technology. The chart reflects the potential of a technology struggling to find its place in the vast medical technology market.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization DXR
Daxor Corporation produces diagnostic equipment for measuring blood volume. Its monthly performance reflects the pace of hospital adoption of its BVA-100 technology. Quarterly reports on system sales and growth in the number of tests performed are the main drivers of its value.
Monthly dynamics of market capitalization of the market segment - Diagnostic medical equipment
The diagnostic equipment market is an important, yet often conservative, segment of healthcare. Its market capitalization dynamics, shown in the graph, reflect clinics' demand for new diagnostic methods. Companies like Daxor Corporation are promoting their unique technologies in this niche.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Daxor Corporation produces blood volume measurement equipment. As a niche medical device manufacturer, its shares are driven by news of technology adoption in hospitals rather than by general market trends, creating an independent profile.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization DXR
Daxor, a manufacturer of blood volume measuring devices, depends on the pace of hospital adoption of its technology. News of new clinical data confirming the benefits of the test, as well as contracts with hospital networks, could trigger short-term price increases.
Weekly dynamics of market capitalization of the market segment - Diagnostic medical equipment
Daxor and the entire niche diagnostic equipment industry are responding to general hospital purchasing cycles. Hospital budgets and insurance policies are drivers for everyone. The chart will show how a small player compares to industry giants.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Daxor and the entire niche diagnostic equipment industry are responding to general hospital purchasing cycles. Hospital budgets and insurance policies are drivers for everyone. The chart will show how a small player compares to industry giants.
Market capitalization of the company, segment and market as a whole
DXR - Market capitalization of the company DXR
Daxor's market capitalization is the financial valuation of a company that has been promoting its unique technology for measuring patients' blood volume for decades. The chart reflects its long struggle for recognition and widespread adoption in clinical practice. Its dynamics tell the story of how innovative medical technology is attempting to change established standards.
DXR - Share of the company's market capitalization DXR within the market segment - Diagnostic medical equipment
Daxor Corporation developed the BVA-100, a diagnostic device for accurately measuring blood volume in patients, which is critical in the treatment of heart failure and sepsis. Its market share reflects its dominance in this highly niche field. The chart below shows the market share of this unique diagnostic tool.
Market capitalization of the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of a unique blood volume measurement system. The chart below shows the overall market capitalization of the diagnostic equipment sector. Its dynamics reflect the search for more accurate diagnostic methods. Daxor proves that even a niche product can have great potential.
Market capitalization of all companies included in a broad market index - GURU.Markets
The diagnostic equipment shown in the graph helps doctors make decisions. Daxor Corporation produces a system for measuring blood volume in critically ill patients. Its capitalization is based on its unique technology, which can aid in the treatment of heart failure and sepsis.
Book value capitalization of the company, segment and market as a whole
DXR - Book value capitalization of the company DXR
Daxor's book value is the physical embodiment of its unique diagnostic technology. The chart reflects the value of its manufacturing facilities, where the BVA-100 blood volume analyzer is manufactured. These tangible assets enable physicians to accurately measure plasma and red blood cell volumes in patients.
DXR - Share of the company's book capitalization DXR within the market segment - Diagnostic medical equipment
Daxor Corporation produces a blood volume analysis system. Its share of the sector's assets lies in its manufacturing and research capabilities. This focused physical base allows it to be the only player in the market with FDA-approved technology for this purpose.
Market segment balance sheet capitalization - Diagnostic medical equipment
Daxor Corporation manufactures diagnostic equipment. It's a moderately capital-intensive business, requiring manufacturing capacity to assemble the BVA-100 blood volume analyzers. Compared to the medical equipment sector, its model is an example of a "heavy-duty" niche equipment manufacturer.
Book value of all companies included in the broad market index - GURU.Markets
Daxor's assets are not CT scanners, but the unique BVA-100 diagnostic system, which is the only FDA-approved method for directly measuring a patient's blood volume. The company's balance sheet reflects the value of this niche but critical technology. The chart shows the capital behind this "gold standard" of hemodynamics.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - DXR
Daxor Corporation produces diagnostic equipment for measuring blood volume. Its market capitalization is based on its patented technology and the potential to become a standard in cardiology and critical care. Investors are evaluating its potential for widespread clinical adoption.
Market to book capitalization ratio in a market segment - Diagnostic medical equipment
Daxor Corporation has developed a blood volume measurement system that could be critical in surgery and intensive care. The company's value lies in its unique diagnostic technology. This chart shows how the market views the potential of this niche yet important medical device.
Market to book capitalization ratio for the market as a whole
Daxor Corporation produces a diagnostic system for measuring blood volume, which is critical in cardiology and intensive care. The company's value lies in its unique technology and patents. This chart demonstrates the premium the market is willing to pay for advanced medical diagnostic solutions, despite its modest book value.
Debts of the company, segment and market as a whole
DXR - Company debts DXR
Daxor Corporation produces diagnostic equipment for measuring blood volume. For a small medical company, growth depends on convincing hospitals of the need for its technology. Borrowed funds can be used for marketing, training clinic staff, and conducting research to prove its effectiveness.
Market segment debts - Diagnostic medical equipment
Daxor Corporation produces diagnostic equipment for measuring blood volume. This is a very niche segment of the medical equipment market. This chart shows how the company finances its operations and efforts to more widely implement its technology in clinical practice, which may require investments in marketing and physician training.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio DXR
Daxor Corporation produces diagnostic equipment for measuring blood volume. This chart shows the company's financial structure. For a niche medical equipment manufacturer, debt can be used for marketing and convincing clinics of the need for their technology. If implementation is delayed, the debt burden could become a problem.
Market segment debt to market segment book capitalization - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the only FDA-approved device for directly measuring blood and plasma volume. This chart compares the company's debt to the overall market capitalization of the entire diagnostic medical equipment sector. It helps assess how the company finances the advancement of its unique and critical technology for critical care.
Debt to book value of all companies in the market
Daxor Corporation produces diagnostic equipment for measuring blood volume. As a niche player in the medical industry, the company can maintain a conservative financial policy. The chart compares its debt load with the medical equipment sector, where many companies use debt to fund R&D and global marketing.
P/E of the company, segment and market as a whole
P/E - DXR
This chart for Daxor Corporation, a manufacturer of diagnostic blood volume measuring equipment, evaluates its niche technology. The price-to-earnings ratio shows whether investors believe their device will become more widely used in hospitals. The price-to-earnings ratio reflects the company's efforts to educate physicians and expand the market.
P/E of the market segment - Diagnostic medical equipment
This chart shows the average valuation for diagnostic equipment manufacturers—the benchmark for Daxor. Comparing this company's valuation, with its very niche technology, to the industry average clearly demonstrates how skeptical the market is about its chances of widespread clinical adoption.
P/E of the market as a whole
Daxor Corporation has developed a system for accurately measuring patients' blood volume, which is critical in treating heart failure and other conditions. It's a niche diagnostic product. This chart reflects the state of the medical technology sector. It helps understand how the company is promoting its product as a new standard of care and how this impacts its growth and valuation.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company DXR
Daxor Corporation has developed a system for accurately measuring patients' blood volume, which is critical in cardiology and intensive care. The company's future profitability depends on the adoption of its technology in hospitals. This chart shows whether analysts believe the BVA-100 will become a diagnostic standard and improve patient outcomes.
%20P%2FE%20DXR&width=1500&height=450&colorIndex=35&filename=GURU_Markets_-_Chart-of-the-companys-future-projected-PE-DXR&v=1772531060212 "Chart of the company's future (projected) P/E DXR")
Future (projected) P/E of the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the BVA-100 system, the only FDA-approved device for direct measurement of blood and red blood cell volume. This chart shows how its profitability expectations compare to the diagnostic equipment sector. It reflects how the market views its unique diagnostic technology and its potential for clinical implementation.
%20P%2FE%20graph%20of%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=36&filename=GURU_Markets_-_Future-projected-PE-graph-of-the-market-segment-Diagnostic-medical-equipment&v=1772531060225 "Future (projected) P/E graph of the market segment - Diagnostic medical equipment")
Future (projected) P/E of the market as a whole
Daxor Corporation has developed a system for measuring blood volume, which is important in the treatment of heart failure and sepsis. This graph illustrates the overall sentiment in the healthcare sector. For Daxor, the focus isn't on economics, but on hospital adoption of their technology. This is a growth story based on evidence of the clinical and cost-effectiveness of their method.
%20P%2FE%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=37&filename=GURU_Markets_-_Chart-of-the-future-projected-PE-of-the-market-as-a-whole&v=1772531060230 "Chart of the future (projected) P/E of the market as a whole")
Profit of the company, segment and market as a whole
Company profit DXR
Daxor Corporation has developed the BVA-100 system for measuring blood and red blood cell volume, which is critical for the diagnosis and treatment of patients in intensive care and with heart failure. This chart shows the financial results of the company, which is promoting this unique diagnostic technology. Success depends on its implementation in clinical practice.
Profit of companies in the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the only FDA-approved device for directly measuring blood and red blood cell volume, the BVA-100. This device aids in the diagnosis and treatment of critically ill patients. This chart shows the overall profitability of the diagnostic equipment sector, demonstrating the demand for accurate and innovative diagnostic methods in medicine.
Overall market profit
Daxor Corporation produces diagnostic equipment for measuring blood volume. Demand for their system is driven by medical needs and acceptance by the medical community. The introduction of new medical technologies is a long-term process that depends less on short-term economic cycles than on clinical data and hospital budgets.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company DXR
Daxor Corporation produces a one-of-a-kind diagnostic system for accurately measuring blood volume in critically ill patients. The company's future depends on the adoption of this technology in hospitals. This chart shows analysts' forecasts for the adoption of this innovative diagnostic method.
%20profit%20of%20the%20company%20DXR&width=1500&height=450&colorIndex=41&filename=GURU_Markets_-_Graph-of-future-projected-profit-of-the-company-DXR&v=1772531060245 "Graph of future (projected) profit of the company DXR")
Future (predicted) profit of companies in the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the only FDA-approved system for directly measuring a patient's blood volume. This chart shows forecasts for the diagnostic equipment sector. Daxor's profitability depends on the implementation of its technology in hospital practice to more accurately manage patients with heart failure and critical illness.
%20profits%20of%20companies%20in%20a%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=42&filename=GURU_Markets_-_Graph-of-future-predicted-profits-of-companies-in-a-market-segment-Diagnostic-medical-equipment&v=1772531060253 "Graph of future (predicted) profits of companies in a market segment - Diagnostic medical equipment")
Future (predicted) profit of the market as a whole
Daxor Corporation produces medical equipment for blood volume analysis, which is important in the treatment of heart failure and sepsis. The implementation of new equipment in hospitals depends on their budgets and willingness to invest in innovation. This graph, showing profit forecasts, helps assess overall financial health, which influences capital expenditures in the healthcare sector.
%20profits%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=43&filename=GURU_Markets_-_Chart-of-future-predicted-profits-of-the-market-as-a-whole&v=1772531060254 "Chart of future (predicted) profits of the market as a whole")
P/S of the company, segment and market as a whole
P/S - DXR
Daxor Corporation developed the BVA-100 system for accurately measuring patients' blood volume, which is critical in cardiology and intensive care. This chart shows how investors estimate the revenue from this unique diagnostic system, reflecting its potential for adoption as a standard of care.
P/S market segment - Diagnostic medical equipment
Daxor Corporation developed the BVA-100, a diagnostic device for accurately measuring blood and plasma volume in patients, which is critical in the treatment of heart failure and sepsis. This chart shows the average rating for medical device manufacturers, helping to understand how the market values Daxor's unique and clinically relevant diagnostic technology.
P/S of the market as a whole
Daxor Corporation has developed the BVA-100 blood volume measuring device, which helps doctors more accurately treat patients with heart failure and critical illnesses. This is a niche diagnostic device. This chart helps assess the market's perception of the company's revenue, as its product could improve treatment standards but requires widespread adoption.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company DXR
Daxor Corporation is the manufacturer of the only FDA-approved blood volume measuring device, the BVA-100, which helps treat patients with heart failure and critical illnesses. This chart shows how investors estimate the company's future revenue. It reflects expectations for the increased adoption of this diagnostic device in hospitals.
%20P%2FS%20DXR&width=1500&height=450&colorIndex=47&filename=GURU_Markets_-_The-graph-of-the-companys-future-projected-PS-DXR&v=1772531060270 "The graph of the company's future (projected) P/S DXR")
Future (projected) P/S of the market segment - Diagnostic medical equipment
Daxor Corporation produces a diagnostic device for measuring blood volume in patients. This chart compares the company's estimated future sales with its industry. It reflects the market's assessment of the extent to which this technology will be adopted by hospitals to more accurately manage patients with heart failure and critical illness.
%20P%2FS%20market%20segment%20graph%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=48&filename=GURU_Markets_-_Future-projected-PS-market-segment-graph-Diagnostic-medical-equipment&v=1772531060274 "Future (projected) P/S market segment graph - Diagnostic medical equipment")
Future (projected) P/S of the market as a whole
Daxor Corporation has developed and markets the BVA-100, a unique diagnostic device for accurately measuring a patient's blood and plasma volume. This graph reflects general expectations, and Daxor represents innovation in diagnostics. The adoption of its technology in hospitals is an indicator of the shift toward more personalized and precise medicine.
%20P%2FS%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=49&filename=GURU_Markets_-_Chart-of-the-future-projected-PS-of-the-market-as-a-whole&v=1772531060298 "Chart of the future (projected) P/S of the market as a whole")
Sales of the company, segment and market as a whole
Company sales DXR
Daxor Corporation produces the only FDA-approved device for directly measuring a patient's blood volume. Revenue, shown in this chart, is generated from sales of this diagnostic equipment and disposable kits to hospitals. This growth reflects the adoption of this technology in clinical practice.
Sales of companies in the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the unique BVA-100 diagnostic system, which accurately measures blood volume in patients. This is a critical indicator for treating heart failure and sepsis. This graph illustrates the dynamics of the medical equipment market, where accurate diagnostics like Daxor's directly impact treatment outcomes.
Overall market sales
Daxor Corporation produces a diagnostic system for measuring blood volume. The implementation of its technology depends on hospitals' willingness to invest in new equipment. The increase in overall economic revenue, reflected in this graph, improves the financial health of medical institutions, allowing them to purchase innovative diagnostic tools to improve patient outcomes.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company DXR
Daxor Corporation has developed the unique BVA-100 system for accurately measuring blood volume in patients, which is critical in the treatment of heart failure and intensive care. This graph shows analysts' expectations for the widespread adoption of this diagnostic tool in clinical practice.
%20sales%20of%20the%20company%20DXR&width=1500&height=450&colorIndex=53&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-the-company-DXR&v=1772531060330 "Schedule of future (projected) sales of the company DXR")
Future (projected) sales of companies in the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the only FDA-approved system for directly measuring blood and plasma volume in patients. This aids in the diagnosis and treatment of heart failure and sepsis. This chart shows forecasts for the diagnostic equipment sector, reflecting the need for accurate measurements for personalized medicine.
%20sales%20of%20companies%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=54&filename=GURU_Markets_-_Schedule-of-future-projected-sales-of-companies-in-the-market-segment-Diagnostic-medical-equipment&v=1772531060332 "Schedule of future (projected) sales of companies in the market segment - Diagnostic medical equipment")
Future (projected) sales of the market as a whole
Daxor Corporation, the developer of a blood volume analysis system, sees this chart as an indicator of the adoption of new technologies in hospitals. The economic growth predicted here allows medical institutions to invest in modern diagnostic equipment that helps improve patient outcomes, for example, for those with heart failure.
%20sales%20of%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=55&filename=GURU_Markets_-_Schedule-of-future-predicted-sales-of-the-market-as-a-whole&v=1772531060333 "Schedule of future (predicted) sales of the market as a whole")
Marginality of the company, segment and market as a whole
Company marginality DXR
Daxor Corporation produces the only FDA-approved system for directly measuring blood volume in patients. The profitability of this niche medical company depends on the widespread adoption of its diagnostic device by hospitals. This chart shows the progress of commercializing this unique technology and turning it into a profitable business.
Market segment marginality - Diagnostic medical equipment
Daxor Corporation produces the BVA-100 diagnostic system for measuring blood volume, which is critical for treating patients in intensive care. The profitability of this niche medical equipment manufacturer depends on the uniqueness of its technology and sales effectiveness. The chart shows how successfully Daxor monetizes its solution compared to the diagnostics sector.
Market marginality as a whole
Daxor Corporation developed the BVA-100 system for accurately measuring patients' blood volume, which is critical in a number of medical conditions. Given its overall cost-effectiveness, Daxor offers a unique diagnostic tool. Their profitability depends on how widely hospitals utilize their technology to improve patient care.
Employees in the company, segment and market as a whole
Number of employees in the company DXR
Daxor Corporation is a pioneer in blood volume measurement. This graph shows its small but focused team. Its size reflects the niche nature of its diagnostic equipment and its efforts to integrate it into clinical practice to improve patient care.
Share of the company's employees DXR within the market segment - Diagnostic medical equipment
Daxor Corporation is the manufacturer of the unique BVA-100 blood volume analysis system, critically important in cardiology and intensive care. This chart shows the share of specialists in the narrow diagnostic equipment niche that Daxor attracts. It reflects its uniqueness and monopoly position in its technological field.
Number of employees in the market segment - Diagnostic medical equipment
Daxor Corporation has developed a blood volume measurement system that aids in the diagnosis and treatment of heart failure and other conditions. Its staff is small, consisting of sales specialists and clinicians. This chart shows how the company is working to implement its niche technology. Growing its staff will signal successful market penetration.
Number of employees in the market as a whole
Daxor Corporation produces blood volume analysis equipment. Demand for this specialized medical equipment is determined not by the general economic situation, but by the medical community's belief in its effectiveness. Therefore, Daxor's hiring dynamics depend more on journal publications than on the data in this chart.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company DXR (DXR)
Daxor produces unique diagnostic equipment. This indicator reflects the value of its technology and production assets. A moderately high value on the chart indicates a balance between capital-intensive production and the company's staff of engineers and service specialists.
%20of%20the%20company%20DXR%20(DXR)&width=1500&height=450&colorIndex=63&filename=GURU_Markets_-_Chart-of-market-capitalization-per-employee-in-thousands-of-dollars-of-the-company-DXR-DXR&v=1772531060430 "Chart of market capitalization per employee (in thousands of dollars) of the company DXR (DXR)")
Market capitalization per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Daxor Corporation produces blood volume analysis equipment, which aids in the diagnosis and treatment of cardiovascular diseases. For a manufacturer of highly specialized medical equipment, this metric reflects the market niche and value of its technology. The graph shows how the market perceives its potential per team.
%20by%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=64&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-by-market-segment-Diagnostic-medical-equipment&v=1772531060482 "Market capitalization per employee (in thousands of dollars) by market segment - Diagnostic medical equipment")
Market capitalization per employee (in thousands of dollars) for the overall market
Daxor Corporation has developed a system for accurately measuring patients' blood volume, which is critical in cardiology and intensive care. It is a niche diagnostics company. This chart shows how the market values a manufacturer of unique medical equipment, where accuracy and clinical benefit generate high value per employee.
%20for%20the%20overall%20market&width=1500&height=450&colorIndex=65&filename=GURU_Markets_-_Market-capitalization-per-employee-in-thousands-of-dollars-for-the-overall-market&v=1772531060507 "Market capitalization per employee (in thousands of dollars) for the overall market")
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company DXR (DXR)
Daxor Corporation produces a diagnostic device (BVA-100) that measures a patient's blood volume. This is a very niche segment of medical equipment. This graph shows how effectively the company's small team can sell and service this unique equipment. Revenue per employee depends on the company's ability to convince hospitals of the need for this test.
%20Chart%20DXR%20(DXR)&width=1500&height=450&colorIndex=66&filename=GURU_Markets_-_Company-Profit-Per-Employee-in-thousands-of-dollars-Chart-DXR-DXR&v=1772531060530 "Company Profit Per Employee (in thousands of dollars) Chart DXR (DXR)")
Profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment
Daxor (DXR) manufactures diagnostic equipment (BVA-100) for measuring blood volume, which is critical for patients with heart failure and in intensive care. This is a niche medical equipment market. This chart shows how efficiently the company sells and services its systems. It reflects revenue generated per employee (sales, service, and production).
%20in%20the%20market%20segment%20-%20Diagnostic%20medical%20equipment&width=1500&height=450&colorIndex=67&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-in-the-market-segment-Diagnostic-medical-equipment&v=1772531060574 "Chart of profit per employee (in thousands of dollars) in the market segment - Diagnostic medical equipment")
Profit per employee (in thousands of dollars) for the market as a whole
Daxor Corporation manufactures diagnostic equipment (BVA-100) for measuring blood volume. This is a niche MedTech product. This chart shows how successfully the company sells and services its devices. The business model likely includes sales of both the equipment itself and its consumables, which, if successfully implemented in clinics, could ensure stable growth in profits per employee.
%20for%20the%20market%20as%20a%20whole&width=1500&height=450&colorIndex=68&filename=GURU_Markets_-_Chart-of-profit-per-employee-in-thousands-of-dollars-for-the-market-as-a-whole&v=1772531060585 "Chart of profit per employee (in thousands of dollars) for the market as a whole")
Sales to employees of the company, segment and market as a whole
Sales per company employee DXR (DXR)
Daxor Corporation produces a diagnostic device for measuring blood volume. This graph demonstrates the effectiveness of their niche business model. It reflects the revenue generated by a small team from sales of specialized medical equipment, and its growth will signify broader adoption of their technology in clinical practice.
&width=1500&height=450&colorIndex=69&filename=GURU_Markets_-_Sales-chart-per-company-employee-DXR-DXR&v=1772531060628 "Sales chart per company employee DXR (DXR)")
Sales per employee in the market segment - Diagnostic medical equipment
Daxor Corporation produces the BVA-100 system for blood volume analysis, which is critical in cardiology and intensive care. It is a niche diagnostic medtech company. This chart shows the average revenue per employee in the sector. It helps assess how productive Daxor is in producing and selling its unique diagnostic equipment to hospitals.
Sales per employee for the market as a whole
Daxor Corporation (DXR) produces the BVA-100, a one-of-a-kind diagnostic device that accurately measures a patient's blood volume. This is critical in cardiology and intensive care. This chart shows how successful their small team is at selling or leasing these expensive devices to hospitals.
Short shares by company, segment and market as a whole
Shares shorted by company DXR (DXR)
Daxor Corporation produces diagnostic equipment (BVA-100) for measuring blood volume, which is important in the treatment of heart failure and sepsis. This is a very narrow niche. The chart shows the number of "bears" who bet that the company's technology will remain niche and will not be widely adopted by hospitals due to its complexity or lack of clear advantages.
&width=1500&height=450&colorIndex=72&filename=GURU_Markets_-_Short-Shares-Chart-for-the-Company-DXR-DXR&v=1772531060703 "Short Shares Chart for the Company DXR (DXR)")
Shares shorted by market segment - Diagnostic medical equipment
Daxor Corporation offers a unique BVA-100 technology for accurately measuring a patient's blood volume. This chart illustrates the overall pessimism in the sector. If it rises, investors doubt that niche diagnostic tests (even useful ones) will be widely adopted or reimbursed by insurers, which is holding back the entire industry.
Shares shorted by the overall market
Daxor Corporation offers a unique diagnostic system, the BVA-100, for measuring blood volume, which is critical for patients in intensive care. Despite its product, DXR is a small company in a niche market. When this chart signals general market fear, investors often flee "thin" (illiquid) small-company stocks, fearing volatility.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator DXR (DXR)
Daxor Corporation specializes in diagnostic equipment for measuring blood volume, which is important for patients with heart failure. This indicator helps assess whether the company's shares are "overheated" (above 70) or "oversold" (below 30) in anticipation of new contracts or reports on the implementation of their technology in clinics.
&width=1500&height=450&colorIndex=75&filename=GURU_Markets_-_RSI-14-indicator-chart-for-the-companys-stock-DXR-DXR&v=1772531060795 "RSI 14 indicator chart for the company's stock DXR (DXR)")
RSI 14 Market Segment - Diagnostic medical equipment
Daxor (DXR) is a blood "meter." They're *not* a test, but a *machine* (BVA-100) that *accurately* measures a patient's *blood volume* (critical in *intensive care*). The "Diagnostic medical equipment" (medtech) sector thrives on R&D. RSI\_14\_Seg shows whether the *entire* sector is "overbought." This helps differentiate: is DXR's rise a niche or a general "overheating"?
RSI 14 for the overall market
Daxor (DXR) produces diagnostic equipment. This chart reflects hospitals' willingness to implement expensive innovations. During periods of euphoria and budget increases, clinics eagerly purchase new technologies. During times of panic and cost-cutting, they may postpone DXR implementation in favor of cheaper, standard methods.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast DXR (DXR)
Daxor (DXR) produces a diagnostic system (BVA-100) that measures a patient's blood volume, which is critical in cardiology and intensive care. This chart shows the average target price. It reflects analysts' opinions on the rate of adoption of this niche diagnostic technology in hospitals.
&width=1500&height=450&colorIndex=78&filename=GURU_Markets_-_A-chart-showing-analyst-consensus-forecasts-for-the-expected-stock-price.-DXR-DXR&v=1772531060868 "A chart showing analyst consensus forecasts for the expected stock price. DXR (DXR)")
The difference between the consensus estimate and the actual stock price DXR (DXR)
Daxor (DXR) is a medtech veteran that produces a diagnostic device (BVA-100) for accurately measuring blood volume, which is critical in cardiology and intensive care. This chart shows their "pivot" estimate. It measures the gap between the price and the consensus target, reflecting whether analysts believe their technology will finally be adopted.
&width=1500&height=450&colorIndex=79&filename=GURU_Markets_-_A-chart-showing-the-difference-between-the-consensus-forecast-and-the-actual-stock-price.-DXR-DXR&v=1772531060887 "A chart showing the difference between the consensus forecast and the actual stock price. DXR (DXR)")
Analyst consensus forecast for stock prices by market segment - Diagnostic medical equipment
Daxor Corporation is a medical device company that produces the BVA-100 diagnostic system, the only FDA-approved method for directly measuring a patient's blood volume. This chart shows general expectations for the diagnostic equipment sector, reflecting whether experts believe there will be demand for this niche but important diagnostic.
Analysts' consensus forecast for the overall market share price
Daxor produces a niche diagnostic tool called the "blood volume analyzer." It's a "bricks and shovels" for hospital costs. This chart, showing the collective market forecast, is key. When analysts are optimistic, hospitals are confident and invest in "new" diagnostic equipment. During a recession (pessimism), CAPEX budgets are frozen.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index DXR
Daxor is an unseen player in cardiology. They produce a diagnostic system (BVA-100), which is the only FDA-approved method for directly measuring a patient's blood volume. This is critical in treating heart failure. This chart is a summary of their razor and blade products. It reflects their slow adoption of razors (devices) and their growth potential from blades (disposables).
AKIMA Market Segment Index - Diagnostic medical equipment
Daxor Corporation (DXR) produces a diagnostic device (BVA-100) that measures a patient's blood and plasma volume. This is a critical indicator for treating heart failure and sepsis. The chart shows the segment average. This allows investors to assess how well Daxor is promoting its unique diagnostic solution compared to the sector average.
The AKIM Index for the overall market
Daxor is a medical technology company that produces the BVA-100 system for accurately measuring blood volume. This chart, which reflects the market average, provides context. It helps assess how this niche diagnostic, which is striving to become the standard of care for heart failure, stacks up against overall macroeconomic trends.
